Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.

导出 OA

翻译打印收藏纠错

作者： Ivana,Beesham ^[1] ; Julia D,Welch ^[2] ; Renee,Heffron ^[3] ; Melanie,Pleaner ^[4] ; Lara,Kidoguchi ^[3] ; Thesla,Palanee-Phillips ^[4] ; Khatija,Ahmed ^[5] ; Deborah,Baron ^[4] ; Elizabeth A,Bukusi ^[3] ; Cheryl,Louw ^[6] ; Timothy D,Mastro ^[7] ; Jennifer,Smit ^[8] ; Joanne R,Batting ^[2] ; Mookho,Malahleha ^[1] ; Veronique C,Bailey ^[9] ; Mags,Beksinska ^[5] ; Deborah,Donnell ^[5] ; Jared M,Baeten ^[1] ; ECHO Trial Consortium ^[3]

作者单位： MatCH Research Unit (MRU), Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa. ^[1] FHI 360, Durham, NC, USA. ^[2] University of Washington, Seattle, WA, USA. ^[3] Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. ^[4] Setshaba Research Centre, Tshwane, South Africa. ^[5] Kenya Medical Research Institute (KEMRI), Nairobi, Kenya. ^[6] Madibeng Centre for Research, Brits, South Africa. ^[7] Department of Family Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. ^[8] Effective Care Research Unit (ECRU), Fort Hare and Eastern Cape Department of Health, Universities of the Witwatersrand, East London, South Africa. ^[9]

关键词 HIV clinical trials pre-exposure prophylaxis standard of care women